CD274 and acute myeloid leukemia: One intravenous injection of 1 × 106, 1 × 107, or 1 × 108 TCID50 was administered to C57BL/6j mice to treat C1498 cell-based acute myeloid leukemia in combination with anti-PD-L1 Ab [39].